|
Resolution: standard / high Figure 1.
Resistin, S100A12 and soluble receptor for advanced glycation end products (sRAGE)
levels at different stages of Kawasaki disease (KD) in patients treated with intravenous
immunoglobulin (IVIG). KD-I, acute stage; KD-II, afebrile stage; KD-III, subacute stage.
Qi et al. Arthritis Research & Therapy 2012 14:R251 doi:10.1186/ar4094 |
